Predicting Response to BRAF-Targeted Therapy Using an Immune Signature

被引：0
|
作者：
Cintolo-Gonzalez, J. A. [1 ]
Hammond, M. [1 ]
Frederick, D. [1 ]
Lawrence, N. [1 ]
Piris, A. [2 ]
Flaherty, K. [1 ]
Wargo, J. [3 ]
Cooper, Z. [3 ]
Hoang, M. [1 ]
Kwong, L. [3 ]
Boland, G. [1 ]
机构：
[1] Massachusetts Gen Hosp, Surg, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P239
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [21] Prognostic Clinical and Radiographic Biomarkers for BRAF-Targeted Therapy in Advanced Melanoma
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Johnson, Douglas B.
    [J]. ONCOLOGIST, 2021, 26 (02): : E333 - E335
  • [22] BRAF-Targeted Therapy in the Treatment of BRAF-Mutant High-Grade Gliomas in Adults
    Johanns, Tanner M.
    Ansstas, George
    Dahiya, Sonika
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (04): : 451 - 454
  • [23] Suppression of Spry1 sensitizes cutaneous melanoma to BRAF-targeted therapy
    Giurato, Giorgio
    Colizzi, Francesca
    Rizzo, Aurora
    Martorelli, Debora
    Montico, Barbara
    Mastorci, Katy
    Benedetti, Dania
    Weisz, Alessandro
    Dolcetti, Riccardo
    Luca, Sigalotti
    Fratta, Elisabetta
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [24] Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies
    Dulgar, Ozgecan
    Kutuk, Tugce
    Eroglu, Zeynep
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (01) : 1 - 10
  • [25] Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies
    Ozgecan Dulgar
    Tugce Kutuk
    Zeynep Eroglu
    [J]. American Journal of Clinical Dermatology, 2021, 22 : 1 - 10
  • [26] Targeting lipid metabolism to improve efficacy of braf-targeted therapy in colorectal cancer
    Geisen, Mariah E.
    He, Dang
    Wang, Chi
    Kolesar, Jill M.
    Zaytseva, Yekaterina
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [27] Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies
    Whittaker, Steven
    Kirk, Ruth
    Hayward, Robert
    Zambon, Alfonso
    Viros, Amaya
    Cantarino, Neus
    Affolter, Annette
    Nourry, Arnaud
    Niculescu-Duvaz, Dan
    Springer, Caroline
    Marais, Richard
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (35)
  • [28] The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy
    Hao, Jiaojiao
    Xu, Hua
    Luo, Meihua
    Yu, Wendan
    Chen, Miao
    Liao, Yina
    Zhang, Changlin
    Zhao, Xinrui
    Jiang, Wei
    Hou, Shuai
    Feng, Xu
    Zou, Kun
    Chen, Yiming
    Huang, Wenlin
    Guo, Wei
    Kang, Lan
    Deng, Wuguo
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (01) : 159 - 170
  • [29] BRAF-Targeted Therapy to Treat Superior Vena Cava Syndrome in a Patient With Metastatic Cancer
    Mesko, Shane M.
    Rosenthal, Katherine J.
    Boasberg, Peter D.
    Hamid, Omid
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : E101 - E103
  • [30] BRAF-targeted therapy for locally advanced ameloblastoma of the mandible: A potential neoadjuvant strategy.
    Grynberg, Shirly
    Steinberg, Yael
    Asher, Nethanel
    Ben-Betzalel, Guy
    Stoff, Ronen
    Markel, Gal
    Shapira-Frommer, Ronnie
    Schachter, Jacob
    Hirschhorn, Ariel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345